Fiche publication
Date publication
juillet 2018
Journal
Annales pharmaceutiques francaises
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DESAUBRY Laurent
,
Dr NEBIGIL-DESAUBRY Canan
Tous les auteurs :
Nebigil CG, Désaubry L
Lien Pubmed
Résumé
Cardio-oncology is a new discipline that focuses on understanding, detection, monitoring and treating cardiovascular disease during and after cancer treatment. The development of this emerging field is based on an interdisciplinary collaboration between cardiology and oncology researchers and clinicians. Cardio-oncology aims at identifying how cancer therapies impact cardiovascular homeostasis, particular risk factors, diagnostic biomarkers and novel therapeutic approaches to help to effectively detect, prevent and cure the cardiotoxicity.
Mots clés
Antineoplastic Agents, adverse effects, Cardiology, standards, Cardiotoxicity, Certification, Heart Diseases, chemically induced, Humans, Medical Oncology, standards, Neoplasms, complications, Patient Care Team
Référence
Ann Pharm Fr. 2018 Jul 31;:
